Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus

Hypertension

Volumn 34, Issue 1, 1999, Pages 83-88

  Sung, Bong Hee ^a,b   Izzo Jr , Joseph L ^a   Dandona, Paresh ^a   Wilson, Michael F ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b MILLARD FILLMORE HOSPITAL   (United States)

Author keywords

Blood pressure; Insulin; Stress, mental; Troglitazone; Vasodilation

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; INSULIN; TROGLITAZONE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARITHMETIC; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASODILATATION;

EID: 0344780882     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.83     Document Type: Article

References (34)

1. Simonaon DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care. 1988;11:821-827.
2. Rosenstock J, Raskin P. Hypertension in diabetes mellitus. Cardiol Clin. 1988;6:547-560.
3. Morales PA, Mitchell BD, Valdez RA, Hazerda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects: the San Antonio Heart Study. Diabetes. 1993;42:154-161.
4. Mogensen CE, Christensen CK. Predicting diabetes nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
5. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension. 1995;26: 869-879.
6. Gall MA, Borch-Johnsen K, Houggard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995;44:1303-1309.
7. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle age diabetic men: a general population study. BMJ. 1989;299: 1127-1131.
8. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol. 1990;15(suppl 5):S18-S25.
9. Bonner G. Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol. 1994;24(suppl):S39-S49.
10. Morris AD, Connell JMC. Insulin resistance and essential hypertension: mechanisms and clinical implications. Am J Med Sci. 1994;307(suppl): S47-S52.
11. Weidmann P, de Courten M, Bohlen L. Insulin resistance, hyperinsulinemia, and hypertension. J Hypertens. 1993;11(suppl 5):S27-S38.
12. Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hyper-tensives. Am J Hypertens. 1995;8:316-320.
13. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188-1193.
14. Song J, Walsh MF, Igwe R, Ram JL, Barazi M, Dominguez LJ, Sowers JR. Troglitazone reduces contractility by inhibition of vascular smooth muscle cell Ca2+ current and not endothelial nitric oxide production. Diabetes. 1997;46:659-664.
15. Fujishima S, Ohhya Y, Nakamura Y, Onaka U, Abe I, Fujishima M. Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. Am J Hypertens. 1998;11:1134-1137.
16. Sung BH, Wilson MF, Izzo JL Jr, Ramirez L, Dandona P. Moderately obese insulin-resistant women exhibit abnormal vascular reactivity to stress. Hypertension. 1997;30:848-853.
17. Matthews KA, Woodall KL, Allen MT. Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension. 1993;22:479-485.
18. Mundal R, Kjedsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts cardiovascular mortality in middle-aged men. Hypertension. 1994;24:56-62.
19. Falkner B, Onesti G, Angelakos ET, Fernandes M, Langman C. Cardiovascular response to mental stress in normal adolescents with hypertensive parents. Hypertension. 1979;1:23-30.
20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Fergenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
21. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2433-2439.
22. Schmitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in non-insulin-dependent diabetes. Diabetoiogia. 1994;37:1251-1258.
23. Moan A, Nordby G, Rostrup M, Eide I, Kjeldsen SE. Insulin sensitivity, sympathetic activity and cardiovascular reactivity in young men. Am J Hypertens. 1995;8:268-275.
24. Jern S. Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm. Hypertension. 1994;24:686-694.
25. Grover A, Padgington C, Wilson, MF, Sung BH, Izzo JL Jr, Dandona P. Insulin attenuates norepinephrine-induced venoconstriction: an ultrasonographic study. Hypertension. 1995;25(pt 2):779-784.
26. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO III, Panza JA. Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol. 1997;80:1070-1074.
27. Petrie JR, Uede S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93: 1331-1333.
28. Kotchen TA, Reddy S, Zhang HY. Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat. Am J Hypertens. 1997;10:1020-1026.
29. Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H. Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism. 1993;42:75-80.
30. Saku K, Zhang B, Ohta T, Arakawa K. Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits. Am J Hypertens. 1997;10:1027-1033.
31. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981;30:219-225.
32. Berne C, Fatius J, Niklasson F. Sympathetic response to oral carbohydrate administration. J Clin Invest. 1989;84:1403-1409.
33. Buchanan TA, Meehan WP, Jeng Y, Yang, D, Chan TM, Nadler JL, Scott S, Rude RK, Hsueh WA. Blood pressure lowering by pioglitazone: evidence for a direct vascular effect. J Clin Invest. 1995;96:354-360.
34. Dubey RK, Zhang HY, Reddy SR, Boegehold MA, Kotchen TA. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol. 1993;265:R726-R732.